Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $91.93M in the twelve months ending March 31, 2024, with 173.52% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $25.97M with 126.41% year-over-year growth. In the year 2023, Rhythm Pharmaceuticals had annual revenue of $77.43M with 227.56% growth.

• Revenue (ttm): $91.93M
• Revenue Growth: +173.52%
• P/S Ratio: 28.08
• Revenue / Employee: $406,752
• Employees: 226
• Market Cap: 2.58B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.